Jeito Capital chooses Precirix, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology as its ninth investment.
The financing will allow Precirix to advance its pipeline of precision radiopharmaceuticals.
Total raised: $88.41M
Investors 5
| Date | Name | Website |
| 18.03.2022 | Jeito Capi... | jeito.life |
| - | V-Bio Vent... | v-bio.vent... |
| - | Forbion | forbion.co... |
| 16.06.2022 | GIMV | gimv.com |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.03.2022 | Series B | $88.41M | Jeito Capi... |
Mentions in press and media 15
| Date | Title | Description | Source |
| 14.09.2022 | Precirix enters into collaboration with Eckert & Ziegler... | Brussels, Belgium and Berlin, Germany, 12 September 2022 – Precirix NV and Eckert & Ziegler Euro... | healthcap.... |
| 09.08.2022 | Precirix and Eckert & Ziegler sign agreement on priority... | Brussels, Belgium and Berlin, Germany, 26 July 2022 – Precirix NV, a clinical-stage biotechnology co... | healthcap.... |
| 10.06.2022 | Precirix presents preclinical data of its FAP-targeting comp... | Brussels, Belgium, 10 June 2022 – Precirix NV, a clinical-stage biotechnology company developing pre... | healthcap.... |
| 31.05.2022 | Precirix strengthens patent portfolio of its precision radio... | Brussels, Belgium, 31 May 2022 – Precirix NV, a clinical-stage biotechnology company developing prec... | healthcap.... |
| 17.03.2022 | Precirix raises EUR 80m in Series B to advance its pipeline ... | Brussels, Belgium, 16 March 2022 – Precirix NV, a clinical-stage biotechnology company developing pr... | healthcap.... |
| 17.03.2022 | Precirix picks up €80M Series B | Precirix has raised €80 million in a round co-led by Jeito Capital, Forbion and Inkef Capital. The B... | pitchbook.... |
| 17.03.2022 | Precirix Raises €80M in Series B Funding | Precirix NV, a Brussels, Belgium-based clinical-stage biotechnology company, raised €80M in Series B... | finsmes.co... |
| 17.03.2022 | Belgian biotech company Precirix secures €80M from Amsterdam... | Brussels-based Precirix, a platform developing radio-immunotherapeutic drugs for cancer patients, an... | siliconcan... |
| 16.03.2022 | Belgian biotech Precirix snags $88M to bankroll radiopharmac... | Precirix, spun out of Vrije Universiteit Brussel (VUB) in 2014, wants to go after well-validated and... | fiercebiot... |
| 16.03.2022 | Forbion co-leads EUR 80m Series B investment in Precirix to ... | Naarden, The Netherlands - 16 March 2022 – Forbion, a leading European life sciences venture capital... | forbion.co... |
Show more